US › Healthcare

Lifecore Biomedical Inc. (LFCR)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$4.35-0.91%
Last close · 2026-08-04

Latest quarter · ended 2026-02-28

Revenue
$23.2M
Revenue YoY
-28.8%
Net profit
$-15.0M
Profit YoY
-128.0%
EPS
$-0.43
EPS estimate
$-0.17
Net margin
-64.6%

EPS came in at -0.43 against a street estimate of -0.17 — a miss of 152.9%.

Key statistics

Market cap
$164.7M
Forward P/E
6.8
P/B
192.10
Book value
$-0.76
EPS (TTM)
$-1.27
52-week high
$8.98
52-week low
$3.63
50-day MA
$5.04
200-day MA
$6.24
Beta
1.09

Analyst view

Analysts rate Lifecore Biomedical Inc. a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $6.83.

Shareholding

Insiders
2.83%
Institutions
77.64%

Largest institutional holders

FundStake
Wynnefield Capital Inc12.55%
Legion Partners Asset Management, LLC11.91%
Greenhaven Road Investment Management, L.P.9.44%
325 Capital LLC5.77%
BlackRock Inc5.01%
Vanguard Capital Management, LLC3.44%
Geode Capital Management, LLC2.17%
Morgan Stanley - Brokerage Accounts2.04%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Lifecore Biomedical Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.